'Risk-benefit' assessment for comprehensive safety evaluation of Chinese patent medicines containing four common toxic ingredients: an analysis of clinical risk factors
对含有四种常见毒性成分的中成药进行综合安全性评价的“风险效益”评估:临床风险因素分析
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1324509
Zhang, Nan; Zhong, Changming; Liu, Guoxiu; Li, Siyu; Lin, Li; Wei, Namin; Song, Yu; Wan, Xiaoqing; Wang, Yanping; Wang, Yongyan; Wu, Wanlin; Qian, Zhongzhi; Zhai, Huaqiang